Boston, MA -- (SBWIRE) -- 09/11/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Cousins Properties Inc (NYSE:CUZ), Hercules Offshore, Inc.(NASDAQ:HERO), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Clean Energy Fuels Corp. (NASDAQ:CLNE)
Cousins Properties Inc (NYSE:CUZ) shares gained 0.99% and closed at $10.18. The company on Sept. 9 announced that it has closed two mortgages, at Post Oak Central and Promenade, generating approximately $303 million in proceeds.
The Post Oak Central non-recourse mortgage, totaling approximately $189 million, has a 7 year term and a fixed rate of 4.26%. Cousins purchased Post Oak Central, a Class-A office complex comprising 1.3 million square feet in the Galleria submarket of Houston, in February 2013 for approximately $233 million. The building is currently 94% leased, up from 92% leased at the time of purchase.
How Should Investors Trade CUZ After The Recent Volatility? Get Free Report Here
Hercules Offshore, Inc.(NASDAQ:HERO) shares fell 2.44% and closed at $7.59. Wunderlich Securities analyst Todd P. Scholl initiated coverage on Hercules Offshore on Sept. 4 with a Buy rating and $13.00 price target.
Additionally, the company, on Sept. 3, announced that it has signed a contract with Cairn India Limited for use of the Hercules Triumph (formerly Discovery Triumph) in the Indian Ocean. Total contract value is approximately $36.6 million, which includes approximately $13 million of mobilization and demobilization fees, to be earned over an estimated 110 days. Contract commencement is expected in late October 2013.
How Should Investors Trade HERO After The Recent Volatility? Get Free Report Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares declined 2.75% to $4.07. The company on August 22 announced that the British Journal of Cancer has published the paper "A Multinational Phase 2 Study of Nanoliposomal Irinotecan Sucrosofate (PEP02, MM-398) for Patients with Gemcitabine-Refractory Metastatic Pancreatic Cancer" in its latest issue. The Phase 2 study evaluated MM-398 (liposomal irinotecan sucrosulfate) monotherapy in patients with metastatic pancreatic cancer previously treated with gemcitabine-based therapy.
Is MACK A Good Buy After The Recent Price Movement? Find Out Here
Clean Energy Fuels Corp. (NASDAQ:CLNE) shares decreased 4.11% to $12.48. The company on Sept. 10 announced the pricing of its private offering of $220 million aggregate principal amount of convertible senior notes due 2018 (the "notes"). The size of the offering was increased from the previously announced $200 million aggregate principal amount. Clean Energy has also granted the initial purchasers of the notes a 30-day option to purchase up to $30 million aggregate principal amount of additional notes. The sale of the notes is expected to close on September 16, 2013, subject to customary closing conditions.
Is CLNE A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)